CASSAVA AND TUNA FISH FORMULA (SIKANTONG) AND APPLICATION IN THE PRODUCT FOR TREATING OF STUNTING CHILDREN

Abstract

Stunting is a chronic malnutrition problem caused by insufficient nutritional intake for a long period. This study aims to produce a food formula made from cassava (singkong) and tuna fish (tongkol) with the name is Sikantong Formula. Sikantong contains high nutritional value, especially energy, carbohydrates, protein and minerals to overcome stunting problems. The study was designed with a randomized group trial design with five types of formulations such as P1, P2, P3, P4 and P5. The quality characters of the Sikantong formula that were tested included the analysis of nutrients in the form of energy, protein, fat, carbohydrates, zinc, iron and calcium. and organoleptic assesment  covering color, aroma, texture, taste and overall acceptance. The results of the study, the five formulations had high nutritional content (> 10% RDA) as a snack food. Based on organoleptic assessment in the application of nuggets and meatballs, the Sikantong P1 formula was chosen as the best formula with a composition of 70 g of cassava flour and 30 g of tuna fish flour. Organoleptic assessment of the P1 formula for nuggets product was significantly different (p <0.05) compared to P2, P3, P4 and P5. The meatball product organoleptic assessment P1 was significantly different in texture, color and aroma (p <0.05) and not significantly different from the taste with the P2, P3, P4 and P5 formulas. Based on the nutritional characteristics, P1 nugget and P1 meatballs formula can recommended as a snack because contains of 5 - 10% of the RDA, such as energy protein,  fat, carbohydrates, zinc, Fe and calcium with 100 grams as a standard portion.  In terms of product prices, the selected formula is the most economical formula compared to other formulas. The conclusion from this study is that Sikantong P1 formula as the chosen formula can be used as an alternative to the development of various food products in fulfilling nutritional adequacy in the prevention and management of stunting in children 1 – 5 years.